health
Eli Lilly & Co
The latest news, analysis and opinion on Eli Lilly & Co. In-depth analysis, industry insights and expert opinion
TL;DR
- Eli Lilly's weight-loss drugs are driving substantial profit increases and market value growth.
- The company is investing in AI for drug discovery through collaborations with biotech firms.
- Eli Lilly is engaged in global negotiations regarding drug pricing, including with the UK's NHS.
- Competition in the weight-loss drug market is intensifying, with Novo Nordisk as a key rival.
- Regulatory bodies are monitoring potential side effects of weight-loss drugs like pancreatitis.
- Pharmaceutical companies are exploring both injectable and oral formulations for weight-loss treatments.
- Eli Lilly achieved a significant milestone by becoming the first pharmaceutical group to join the $1 trillion market cap club.
- The US is looking to reduce the prices of obesity drugs offered on specific platforms.